Webinar and Symposia
The advantage of the Acutis webinars lies in their interactivity.
In a webinar, you are both a member of the audience and, if you choose, a participant, where you’ll have the opportunity to share your ideas and ask questions to deepen your understanding of the topic.
Acutis Symposia are professional and social events that truly matter. Each symposium, led by a distinguished speaker, will provide clients, colleagues, and others with the opportunity to meet and discuss the most critical issues facing the industry today.
Acutis Webinars On Demand
Protect your practice from COVID-19
March 19, 2020
Led by Michelle Leger, Director of Quality Assurance and featuring Dr. Marjorie Bon Homme, Chief Scientist & Laboratory Director
During one hour, she covered the following key points:
-
Discussion of the current COVID-19 environment and information on pathogen transmission
-
Explanation of actionable short-term and long-term methods to maintain a clean work environment and prevent the spread of infection
-
Sharing of healthcare industry-specific best practices on maintaining a healthy and safe workplace
The focus of this seminar was on healthcare professionals in settings where they are not directly treating patients for COVID-19, but who may be exposed through patient interactions
(e.g., substance use and addiction treatment).
Thanks, everyone for spending a stimulating and valuable hour together.
Colleagues, peers, and participants can download the contents of our COVID-19 Webinar here.
The Synthetics, Part I: Designer Drugs on the Horizon
July 18, 2019
Led by Dr. Daniela Zaborskis and featuring Senior Researcher, Mumtaz Akhtar
Our Summer Webinar has provided a review and expert opinion in a discussion on the pharmacological, medical, and social implications of designer drugs: synthetic cannabinoids and fentanyl analogs.
The prevalence of these substances constitutes a crisis, which compels us to hone our understanding of these substances and to better deliver the most effective diagnoses and care.
The seminar offered:
-
A summary of two types of designer drugs: fentanyl analogs and synthetic cannabinoids
-
A review of the basic pharmacology of these dangerous and illicit substances
-
A discussion of the seemingly innumerable varieties of drugs being abused
These and other relevant areas of interest were illustrated with case studies and specific “take-home” points.
Buprenorphine Pharmacology and Opioid Neurobiology
March 21, 2019
Led by Dr. Jeffrey Fudin and Dr. Daniela Zaborskis
Our Winter Webinar was led by Dr. Jeffrey Fudin and featured Daniela Zaborskis, PhD., Director of Operations and Senior Scientist, Acutis Diagnostics.
Dr. Fudin has long been recognized as an indispensable resource for medical, pharmacological, pain, and substance-abuse specialists.
As an expert in pain management and pharmacotherapy, Dr. Fudin prepared a set of objectives for the day that included:
-
A summary of the neurobiology of opioid addiction
-
A review of basic pharmacology as it applies to opioids
-
A discussion of the pharmacology and pharmacokinetics of buprenorphine
These and other relevant areas of interest were illustrated with case studies and specific “take-home” points.
In addition to having the opportunity to participate in an important and focused discussion, participants earned continuing medical education credits.
Colleagues, peers, and participants can download the contents of our Winter Webinar here.
Acutis Symposia
“You’re in control or urine control: clinical pearls of drug-testing case studies.”
October 23, 2018
Led by Dr. Jeffrey Fudin, Pharm. D., Clinical pharmacy specialist, opioid risk management
On October 23, 2018, Acutis held its first Autumn Symposium, a dinner featuring Dr. Jeffrey Fudin, Pharm.D., the renowned clinical pharmacy specialist, and opioid risk management specialist. Dr. Fudin spoke on topics related to the treatment of substance abuse & addiction, emphasizing Urine Drug Monitoring (UDM), to an audience of almost 20 physicians, clinicians, and pharmacists.
Dr. Fudin’s talk established 3 Learning Objectives:
-
Differentiating between in-office qualitative testing and laboratory quantitative testing
-
Four case studies: a. Sample validity b. Table scrapping c. THC elimination d. “I swear it’s not cocaine … it’s lidocaine!”
-
Street trends, focus on synthetics and naturally-derived illicit substances.
The focus of this seminar was on healthcare professionals in settings where they are not directly treating patients for COVID-19, but who may be exposed through patient interactions.
Thanks, everyone for spending a stimulating and valuable hour together.
Colleagues, peers and participants can download the contents of Autumn Symposium below.